This course discusses the safety of stereotactic ablative radiotherapy in patients with early non-small cell lung cancer and interstitial lung disease.
The post CME/CE: Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD first appeared on Physician's Weekly.